Why carry out this study?

Cancer patients are prone to infections; fatal infections remain significant causes of death among cancer patients in the modern era.

Understanding the patterns of fatal infections in patients with cancer is imperative. However, the mortality rate of fatal infections remains unclear.

We sought to investigate the characteristics, incidence, and predictive risk factors of fatal infections among a population-based cancer cohort.

What was learned from this study?

Cancer patients were not only at high risk of get infections, but also at high risk of dying from fatal infections.

The findings of this study identified the high-risk population for dying of fatal infections among cancer patients and determined the key population for further prevention and treatment of deadly infections.